News from NORD

NORD Provides Update on Tax Cuts and Jobs Act


 

The Tax Cuts and Jobs Act passed by Congress and signed into law by President Trump includes a reduction of the Orphan Drug Tax Credit (ODTC), a repeal of the Affordable Care Act’s individual mandate, and a temporary bolstering of the Medical Expense Deduction. While NORD supports the temporary strengthening of the Medical Expense Deduction, it opposed the repeal of the individual mandate and the reduction of the ODTC. Thanks to the work of rare disease advocates joining NORD in support for the ODTC, the tax credit was not repealed entirely, as was initially suggested, but rather was cut in half. NORD is grateful for the support it received on this issue and will continue to work to preserve the important orphan drug incentives in 2018.

Recommended Reading

FDA grants breakthrough therapy designation for severe aplastic anemia drug
MDedge Pediatrics
Cornelia de Lange Syndrome Foundation Call for Abstracts
MDedge Pediatrics
HCU Network America Grant Requests
MDedge Pediatrics
National Niemann-Pick Disease Foundation Seeks Executive Director
MDedge Pediatrics
Osteogenesis Imperfecta Foundation Biennial Conference
MDedge Pediatrics
Join 7,000 Miles Campaign to Support Programs for Rare Disease Patients
MDedge Pediatrics
January 12 Is Deadline for Rare Impact Awards Nominations
MDedge Pediatrics
NORD Awards Five Research Grants
MDedge Pediatrics
Visit NORD’s Website to Learn About Current or Future Research Funding Opportunities
MDedge Pediatrics
NORD Launches Year-Long 35th Anniversary Observance
MDedge Pediatrics